http://virometix.com  

8952 Schlieren, Wagistrasse 14

 +41 (0)43 433 86 60
 info@virometix.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

https://vivtex.com/  

8952 Schlieren, Wagistrasse 13

 info@vivtex.com

Vivtex’s proprietary platform enables for the first time the use of intact gastrointestinal tract tissue for fully automated robotic testing. We use this technology to enable the development of new drugs that can be given orally instead of painful and inconvenient needle injections.

https://eu.vvardis.com/  

8952 Schlieren, Wagistrasse 27

At the heart of vVARDIS is the breakthrough biomimetic P11-4 peptide technology that is uniquely capable of treating early-stage caries by regenerating tooth enamel - the only tissue in the body that cannot heal itself. Backed by more than 25 years of research and more than 10 years of clinical practice, the vVARDIS technology has been peer-reviewed in more than 230 publications and is being incorporated into the curricula of renowned dental schools. This breakthrough technology, which is suitable for patients of all ages, stops and eliminates caries in its early stages while preserving the natural tooth structure. No drilling, no anesthesia and no pain.